Anti-DYM monoclonal antibody

Pre-made anti-DYM monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DYM/DYM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0732-Ab-1/ GM-Tg-hg-IP0732-Ab-2Anti-Human DYM monoclonal antibodyHuman
GM-Tg-rg-IP0732-Ab-1/ GM-Tg-rg-IP0732-Ab-2Anti-Rat DYM monoclonal antibodyRat
GM-Tg-mg-IP0732-Ab-1/ GM-Tg-mg-IP0732-Ab-2Anti-Mouse DYM monoclonal antibodyMouse
GM-Tg-cynog-IP0732-Ab-1/ GM-Tg-cynog-IP0732-Ab-2Anti-Cynomolgus/ Rhesus macaque DYM monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0732-Ab-1/ GM-Tg-felg-IP0732-Ab-2Anti-Feline DYM monoclonal antibodyFeline
GM-Tg-cang-IP0732-Ab-1/ GM-Tg-cang-IP0732-Ab-2Anti-Canine DYM monoclonal antibodyCanine
GM-Tg-bovg-IP0732-Ab-1/ GM-Tg-bovg-IP0732-Ab-2Anti-Bovine DYM monoclonal antibodyBovine
GM-Tg-equg-IP0732-Ab-1/ GM-Tg-equg-IP0732-Ab-2Anti-Equine DYM monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0732-Ab-1/ GM-Tg-hg-IP0732-Ab-2; GM-Tg-rg-IP0732-Ab-1/ GM-Tg-rg-IP0732-Ab-2;
GM-Tg-mg-IP0732-Ab-1/ GM-Tg-mg-IP0732-Ab-2; GM-Tg-cynog-IP0732-Ab-1/ GM-Tg-cynog-IP0732-Ab-2;
GM-Tg-felg-IP0732-Ab-1/ GM-Tg-felg-IP0732-Ab-2; GM-Tg-cang-IP0732-Ab-1/ GM-Tg-cang-IP0732-Ab-2;
GM-Tg-bovg-IP0732-Ab-1/ GM-Tg-bovg-IP0732-Ab-2; GM-Tg-equg-IP0732-Ab-1/ GM-Tg-equg-IP0732-Ab-2
Products NameAnti-DYM monoclonal antibody
Formatmab
Target NameDYM
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DYM monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0732-Ag-1Recombinant multi-species DYM/ DMC/ SMC protein


    Target information

    Target IDGM-IP0732
    Target NameDYM
    Gene ID54808,69190,291433,698595,480222,101088525,613923,100053667
    Gene Symbol and Synonyms1810041M12Rik,4933427L07Rik,C030019K18Rik,DMC,DYM,RGD1309111,SMC
    Uniprot AccessionQ7RTS9,B4F766
    Uniprot Entry NameDYM_HUMAN,DYM_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000141627
    Target ClassificationN/A

    The target: DYM, gene name: DYM, also named as DMC, SMC. This gene encodes a protein which regulates Golgi-associated secretory pathways that are essential to endochondral bone formation during early development. This gene is also believed to play a role in early brain development. This gene is widely expressed in embryos and is particularly abundant in chodrocytes and brain tissues. It encodes a peripheral membrane protein which shuttles between the cytosol and Golgi complex. Mutations in this gene are associated with two types of recessive osteochondrodysplasia: Dyggve-Melchior-Clausen (DMC) dysplasia and Smith-McCort (SMC) dysplasia. [provided by RefSeq, Jun 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.